SCHEMBL6775170

SCHEMBL6775170

CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccc(O)cc4)c3)ncnc2cn1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.83
ERBB2 P04626 15/20 0.83
ERBB4 Q15303 10/20 0.83
MEN1 O00255 1/20 0.83
RGS12 O14924 1/20 0.83
GMNN O75496 1/20 0.83
ALDH1A1 P00352 1/20 0.83
LMNA P02545 1/20 0.83
RAF1 P04049 1/20 0.83
TP53 P04637 1/20 0.83
CYP1A2 P05177 1/20 0.83
CYP3A4 P08684 1/20 0.83
CYP2D6 P10635 1/20 0.83
MAPT P10636 1/20 0.83
CYP2C9 P11712 1/20 0.83
HPGD P15428 1/20 0.83
ALOX15 P16050 1/20 0.83
NFKB1 P19838 1/20 0.83
APEX1 P27695 1/20 0.83
MAPK1 P28482 1/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6767758 0.91 ERBB2 (0.83) EGFRERBB2ERBB4MEN1RGS12
Gw282974X SCHEMBL31061539 0.91 ERBB2 (1.00) EGFRERBB2ERBB4MEN1RGS12
Gw282974X SCHEMBL29556843 0.91 ERBB2 (1.00) EGFRERBB2ERBB4MEN1RGS12
Gw282974X SCHEMBL1737530 0.91 ERBB2 (1.00) EGFRERBB2ERBB4MEN1RGS12
Hydrochloric Acid SCHEMBL7015397 0.90 ERBB2 (0.82) EGFRERBB2ERBB4MEN1RGS12
SCHEMBL6768356 0.86 EGFR (0.84) EGFRERBB2ERBB4MEN1RGS12
Hydrochloric Acid SCHEMBL6767325 0.85 EGFR (0.82) EGFRERBB2ERBB4MEN1RGS12
SCHEMBL6767935 0.85 ERBB2 (0.82) EGFRERBB2ERBB4MEN1RGS12
Hydrochloric Acid SCHEMBL6774156 0.84 ERBB2 (0.81) EGFRERBB2ERBB4MEN1RGS12
SCHEMBL6769454 0.84 ERBB2 (0.80) EGFRERBB2ERBB4MEN1RGS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0912570-B1 BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS GLAXO GROUP LTD (GB) 2003-09-10 EP claimed
US-6723726-B1 Protein tyrosine kinase inhibitors SMITHKLINE BEECHAM CORPORATION 2004-04-20 US disclosed
EP-0912570-B1 BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS GLAXO GROUP LTD (GB) 2003-09-10 EP disclosed
EP-1304110-A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors GLAXO GROUP LIMITED (GB) 2003-04-23 EP disclosed
US-6174889-B1 PROTEIN TYROSINE KINASE INHIBITORS RELATED TO BIOISOSTERES OF QUINOLINE AND QUINAZOLINE DERIVATIVES; ANTICARCINOGENIC AND -TUMOR AGENTS; PSORIASIS; RESTENOSIS; RHEUMATOID ARTHRITIS, AUTOIMMUNE DISEASE, ALLERGY, ASTHMA AND GRAFT REJECTION GLAXO WELLCOME INC. 2001-01-16 US disclosed